Smart Biotech Hedge Fund Worth Watching Had Therapeutics MD Before Pop

July 10, 2014   |   July 2014 Bond Updates
Biotech stock Therapeutics MD (TXMD) was up 32.5% on Tuesday, lifted by brokerage house FBR Capital initiating coverage with an incredible $34 price target. Based on TXMD's Tuesday closing price of $5.47, the FBR price target would mean a 600% return.

View more at: http://www.forbes.com/sites/greatspeculations/2014/07/09/smart-biotech-hedge-fund-worth-watching-had-therapeutics-md-before-pop/
 
Related News
Home| About us | Contact us http://www.bondupdatesdailynews.com/